Quick Answer
Arbutus Biopharma Corp reported Stockholders Equity of $76.58 million for fiscal year 2025.
Arbutus Biopharma Corp Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $76.58M | -21.4% |
| 2024 | $97.37M | -8.2% |
| 2023 | $106.02M | -22.5% |
| 2022 | $136.85M | -19.2% |
| 2021 | $169.44M | +66.2% |
| 2020 | $101.97M | +40.2% |
| 2019 | $72.74M | -63.7% |
| 2018 | $200.23M | +9.7% |
| 2017 | $182.47M | -10.1% |
| 2016 | $203.00M | -62.9% |
| 2015 | $547.68M | +522.1% |
| 2014 | $88.03M | +48.7% |
| 2013 | $59.19M | +44.7% |
| 2012 | $40.92M | +682.7% |
| 2011 | $5.23M | -51.6% |
| 2010 | $10.79M | -52.0% |
| 2009 | $22.46M | -27.4% |
| 2008 | $30.94M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $77.40M | -27.6% | -6.7% |
| June 30, 2025 | $82.98M | -32.2% | +4.8% |
| March 31, 2025 | $79.16M | -30.9% | -18.7% |
| December 31, 2024 | $97.37M | -8.2% | -8.9% |
| September 30, 2024 | $106.89M | -10.4% | -12.7% |
| June 30, 2024 | $122.45M | -9.1% | +6.8% |
| March 31, 2024 | $114.64M | -20.3% | +8.1% |
| December 31, 2023 | $106.02M | -22.5% | -11.2% |
- Arbutus Biopharma Corp showed a decrease of -21.4% in Stockholders Equity compared to the prior fiscal year.
- Over the 2008–2025 period, Arbutus Biopharma Corp’s stockholders equity has grown by 147.5% (from $30.94 million to $76.58 million).
- The most recent figure is from Arbutus Biopharma Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: